| Ytd | -81.24% | |
| 1y | -78.88% |
| Open | 1.64 | Prev Close | 1.68 | Low | 1.48 | High | 1.64 | Mkt Cap | 3.48M |
| Vol | 158.94K | Avg Vol | 3.91M | EPS | -1.58 | P/E | -1.00 | Forward P/E | N/A |
| Beta | 0.97 | Short Ratio | 0.65 | Inst. Own | 12.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.91 | 200-d Avg | 4.50 | 1yr Est | 17.33 |
HC Wainwright & Co. analyst Andrew S. Fein reiterates MetaVia (NASDAQ:MTVA) with a Buy and ma
All Active Patients in Both Cohorts Have Successfully Reached Highest Target Doses of 48 mg and 64 m
GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT
Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing
Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial